Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2019 2
2020 6
2021 11
2022 6
2023 5
2024 8

Text availability

Article attribute

Article type

Publication date

Search Results

36 results

Results by year

Filters applied: . Clear all
Page 1
Global, regional, and national incidence and mortality burden of non-COVID-19 lower respiratory infections and aetiologies, 1990-2021: a systematic analysis from the Global Burden of Disease Study 2021.
GBD 2021 Lower Respiratory Infections and Antimicrobial Resistance Collaborators. GBD 2021 Lower Respiratory Infections and Antimicrobial Resistance Collaborators. Lancet Infect Dis. 2024 Apr 15:S1473-3099(24)00176-2. doi: 10.1016/S1473-3099(24)00176-2. Online ahead of print. Lancet Infect Dis. 2024. PMID: 38636536 Free article.
Global estimates on the number of people blind or visually impaired by cataract: a meta-analysis from 2000 to 2020.
Pesudovs K, Lansingh VC, Kempen JH, Tapply I, Fernandes AG, Cicinelli MV, Arrigo A, Leveziel N, Briant PS, Vos T, Resnikoff S, Taylor HR, Sedighi T, Flaxman S, Steinmetz J, Bourne R; Vision Loss Expert Group of the Global Burden of Disease Study; GBD 2019 Blindness and Vision Impairment Collaborators. Pesudovs K, et al. Eye (Lond). 2024 Mar 9. doi: 10.1038/s41433-024-02961-1. Online ahead of print. Eye (Lond). 2024. PMID: 38461217
RNA therapeutics for kidney injury.
Goleij P, Sanaye PM, Rezaee A, Tabari MAK, Arefnezhad R, Motedayyen H. Goleij P, et al. Among authors: arefnezhad r. Prog Mol Biol Transl Sci. 2024;204:69-95. doi: 10.1016/bs.pmbts.2023.12.007. Epub 2024 Jan 24. Prog Mol Biol Transl Sci. 2024. PMID: 38458744 Review.
Noncoding RNAs and programmed cell death in hepatocellular carcinoma: Significant role of epigenetic modifications in prognosis, chemoresistance, and tumor recurrence rate.
Arefnezhad R, Ashna S, Rezaei-Tazangi F, Arfazadeh SM, Seyedsalehie SS, Yeganeafrouz S, Aghaei M, Sanandaji M, Davoodi R, Abadi SRK, Vosough M. Arefnezhad R, et al. Cell Biol Int. 2024 May;48(5):556-576. doi: 10.1002/cbin.12145. Epub 2024 Feb 27. Cell Biol Int. 2024. PMID: 38411312 Review.
Types of RNA therapeutics.
Goleij P, Babamohamadi M, Rezaee A, Sanaye PM, Tabari MAK, Sadreddini S, Arefnezhad R, Motedayyen H. Goleij P, et al. Among authors: arefnezhad r. Prog Mol Biol Transl Sci. 2024;203:41-63. doi: 10.1016/bs.pmbts.2023.12.022. Epub 2024 Jan 25. Prog Mol Biol Transl Sci. 2024. PMID: 38360005
Breast cancer prediction using different machine learning methods applying multi factors.
Nazari E, Naderi H, Tabadkani M, ArefNezhad R, Farzin AH, Dashtiahangar M, Khazaei M, Ferns GA, Mehrabian A, Tabesh H, Avan A. Nazari E, et al. Among authors: arefnezhad r. J Cancer Res Clin Oncol. 2023 Dec;149(19):17133-17146. doi: 10.1007/s00432-023-05388-5. Epub 2023 Sep 29. J Cancer Res Clin Oncol. 2023. PMID: 37773467
36 results